Nuvectis Pharma Stock Quote NVCT - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

4.95

Bid

4.93

Ask

4.95

Volume

45,037

4.82 Day's Range 5.0926

4.6106 52 Week Range 12.10

Market Cap

95.639M

Previous Close

4.92

Open

4.9606

Last Trade

4.93

Last Trade Time

15:36:19

Financial Volume

$ 221,826

VWAP

4.9254

Average Volume (3m)

178,557

Shares Outstanding

19,320,973

Dividend Yield

PE Ratio

-4.30

Earnings Per Share (EPS)

-1.15

Revenue

Net Profit

-22.26M

Nuvectis Pharma Inc is a biopharmaceutical company. Nuvectis Pharma Inc is a biopharmaceutical company.

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.nuvectis.com

Headquarters

Wilmington, Delaware, USA

Founded

Nuvectis Pharma Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker NVCT. The last closing price for Nuvectis Pharma was $4.92. Over the last year, Nuvectis Pharma shares have traded in a share price range of $ 4.6106 to $ 12.10.

Nuvectis Pharma currently has 19,320,973 shares outstanding. The market capitalization of Nuvectis Pharma is $95.06 million. Nuvectis Pharma has a price to earnings ratio (PE ratio) of -4.30.

Form 4 - Statement of changes in beneficial ownership of securities

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

PESG Releases Market Update: Nuvectis Pharma Shows Promising Synergy for NXP900 in Recent Presentations; Growing Anticipation for Upcoming NXP800 Data Update

Nuvectis Pharma (NASDAQ: NVCT) continues to make strides in precision oncology, gaining momentum following presentations last week at the AACR-NCI-EORTC Symposium where its drug candidate NXP900...

PESG Releases Report on Nuvectis Pharma: With Summit Therapeutics Threatening to Dethrone Merck's Keytruda, Nuvectis' NXP900 is One to Watch

With its focus on targeting well-defined subgroups by inhibiting SRC/YES1 kinases in Non Small-Cell Lung Cancer patients resistant to EGFR and ALK targeted therapies, Nuvectis Pharma’s NXP900...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.09	-1.78571428571	5.04	5.4799	4.82	65379	5.09838672	CS
4	-1.32	-21.0526315789	6.27	11.8	4.6106	290129	6.907903	CS
12	-1.95	-28.2608695652	6.9	11.8	4.6106	178557	7.01723057	CS
26	-1.89	-27.6315789474	6.84	11.8	4.6106	127627	6.9082417	CS
52	-3.45	-41.0714285714	8.4	12.1	4.6106	110645	7.36911591	CS
156	1	25.3164556962	3.95	20.92	3.08	190943	7.87597277	CS
260	1	25.3164556962	3.95	20.92	3.08	190943	7.87597277	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
ZJKZJK Industrial Company Ltd	$ 19.6613 (210.12%)	26.64M
CTNTCheetah Net Supply Chain Service Inc	$ 5.12 (173.80%)	109.69M
GWAVGreenwave Technology Solutions Inc	$ 0.6768 (85.42%)	495.78M
JYDJayud Global Logistics Ltd	$ 1.10 (64.15%)	10.23M
JANXJanux Therapeutics Inc	$ 59.965 (49.24%)	6.4M
REVBRevelation Biosciences Inc	$ 0.5353 (-43.65%)	5.25M
OMEXOdyssey Marine Exploration Inc	$ 0.4501 (-39.60%)	4M
STSSSharps Technology Inc	$ 2.21 (-34.10%)	459.42k
AGFYAgrify Corporation	$ 34.87 (-32.53%)	243.69k
CYCNCyclerion Therapeutics Inc	$ 1.60 (-31.62%)	344.33k
GWAVGreenwave Technology Solutions Inc	$ 0.6776 (85.64%)	495.86M
SMCISuper Micro Computer Inc	$ 40.62 (-3.29%)	191.48M
NVDANVIDIA Corporation	$ 139.97 (0.97%)	125.38M
CHRSCoherus BioSciences Inc	$ 1.7999 (31.38%)	111.25M
CTNTCheetah Net Supply Chain Service Inc	$ 5.12 (173.80%)	111.24M